A cutting-edge mini-review published in the inaugural issue of Targetome elaborates on the value of proteome-wide ...

LET’S GET TECHNICAL. Scientists from the biotech company Life Biosciences are investigating the safety and potential side ...

Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

Today, more people are living past 100 than ever before — even though the maximum human lifespan hasn't moved past 115 years.

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

Biomedical engineers use iPSCs to grow specialized retinal endothelial cells, successfully regenerating damaged eye blood ...

Plant regeneration represents a cornerstone of modern plant science, blending fundamental questions in developmental biology ...

Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...

With fresh focus on New Approach Methodologies (NAMs) to move away from animal models in biosciences and preclinical ...

Sparkling Sciences Co., Ltd., under TOMO YUME Group, announced it has obtained international INCI certification for iPSC Exosome and completed Kyoto University's patent licensing agreement. INCI Name: ...

Researchers are decoding how signals move between body and brain, with implications for how we understand and treat ...

Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial will test a novel ...